Drug Resistant Cells
Drug-resistant cell lines are indispensable tools for unraveling the mechanisms of chemotherapeutic resistance and developing strategies to overcome it in oncology research. By mimicking the adaptive responses of tumors to therapeutic pressure, these models enable the study of resistance pathways, biomarker discovery, and high-throughput drug screening.
Creative Bioarray offers a comprehensive collection of rigorously validated drug-resistant cell lines, developed through systematic exposure to escalating doses of chemotherapeutic agents. Each cell line is characterized for stability under consistent culturing conditions, ensuring reproducible performance in long-term experiments.
Highlights of Our Drug-Resistant Cell Lines
Stability: Guaranteed consistent resistance phenotypes across passages.
Comprehensive Biobanking: Diverse portfolio covering common and rare resistance profiles.
Custom Development: Tailored solutions for specific drugs, concentrations, or genetic backgrounds.
Description: The Adriamycin-resistant cell line HCT8/ADR has been developed by repeatedly exposing the parent ...
Description: The Fluorouracil-resistant cell line HCT8/5FU has been developed by repeatedly exposing the parent ...
Description: The Oxaliplatin-resistant cell line HCT8/L-OHP has been developed by repeatedly exposing the parent ...
Description: The Paclitaxel-resistant cell line HCT-15/taxol has been developed by repeatedly exposing the ...
Description: The Palbociclib-resistant cell line MCF-7/Pal has been developed by repeatedly exposing the parent ...
Description: The Doxorubicin-resistant cell line HepG2/ADR has been developed by repeatedly exposing the parent ...
Description: The Fluorouracil-resistant cell line HCT-15/5FU has been developed by repeatedly exposing the ...
Description: The Paclitaxel-resistant cell line HCT-15/Taxol has been developed by repeatedly exposing the ...
Description: The Paclitaxel-resistant cell line HCT-8/taxol has been developed by repeatedly exposing the parent ...
Description: The Cisplatin-resistant cell line MKN-45/DDP has been developed by repeatedly exposing the parent ...
Description: The Oxaliplatin-resistant cell line MKN-45/L-OHP has been developed by repeatedly exposing the ...
Description: The Gefitinib-resistant cell line HCC-827/GR has been developed by repeatedly exposing the parent ...
Description: The Cisplatin-resistant cell line HCT-116/DDP has been developed by repeatedly exposing the parent ...
Description: The Onvansertib-resistant cell line HCT-116/Onv has been developed by repeatedly exposing the ...
Description: The Paclitaxel-resistant cell line WSU-HN30/Taxol has been developed by repeatedly exposing the ...
Description: The Paclitaxel-resistant cell line CCRF-CEM/Taxol has been developed by repeatedly exposing the ...
Description: The Cisplatin-resistant cell line HOS/DDP has been developed by repeatedly exposing the parent HOS ...
Description: The Cisplatin-resistant cell line Hela S3/DDP has been developed by repeatedly exposing the parent ...